Muscarinic toxins from the green mamba

Pharmacology and Therapeutics

Volumn 85, Issue 2, 2000, Pages 87-109

  Bradley, Karen N ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Mamba; Muscarinic; Receptor; Selective; Subtype; Toxin

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR; MUSCARINIC TOXIN; RECEPTOR SUBTYPE; SNAKE VENOM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BINDING SITE; BRAIN CORTEX; DRUG ANALYSIS; DRUG ISOLATION; HEART ATRIUM; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW;

ANIMALS; BASE SEQUENCE; ELAPID VENOMS; ELAPIDAE; MOLECULAR SEQUENCE DATA; RADIOLIGAND ASSAY; RATS; RECEPTORS, MUSCARINIC; VISUAL CORTEX;

EID: 0033971608     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00064-9     Document Type: Review

References (145)

1. Adem A., Asblom A., Johansson G., Mbugua P.M., Karlsson E. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim Biophys Acta. 968:1988;340-345.
2. 4 muscarinic cholinergic receptors in the rat brain detected by a selective mamba toxin. Life Sci. 56:1995;1013.
3. 1 muscarinic receptors in rat brain using selective muscarinic toxin-1. Brain Res Bull. 44:1997;597-601.
4. Akiba I., Kubo T., Maeda A., Bujo H., Nakai J., Mishina M., Numa S. Primary structure of porcine muscarinic receptor III and antagonist binding studies. FEBS Lett. 23:1988;257-261.
5. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol. 6:1994;180-190.
6. Baumgold J., White T. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition. Biochem Pharmacol. 38:1989;1605-1616.
7. Birdsall N.J.M., Hulme E.C. Biochemical studies on muscarinic acetylcholine receptors. J Neurochem. 27:1976;7-16.
8. Birdsall N.J.M., Burgen A.S.V., Hulme E.C. The binding of agonists to brain muscarinic receptors. Mol Pharmacol. 14:1978;723-736.
9. Birdsall N.J.M., Hulme E.C., Kromer W., Stockton J.M. A second drug binding site on muscarinic receptors. Fed Proc. 46:1987;2525-2527.
10. Birdsall N.J.M., Farries T., Gharagozloo P., Kobayashi S., Kuonen D., Lazareno S., Popham A., Sugimoto M. Selective enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Life Sci. 60:1997;1047-1052.
11. Blüml K., Mutshcler E., Wess J. Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. J Biol Chem. 269:1994;18870-18876.
12. Bonner T., Buckley N., Young A., Brann M. Identification of a family of muscarinic acetylcholine receptors genes. Science. 237:1987;527-532.
13. Bonner T., Young A., Brann M., Buckley N. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron. 1:1988;403-410.
14. Bourdon H., Trumpp-Kallmeyer S., Schreuder H., Hoflack J., Hibert M., Wermuth C.-G. Modelling of the binding site of the human m1 muscarinic receptor. experimental validation and refinement J Comput Aided Mol Des. 11:1997;317-332.
15. Bowersox S.S., Luther R. Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111); an N-type neuronal calcium channel blocker found in the venom of the Conus magus. Toxicon. 36:1998;1651-1658.
16. Bradley K.N., Rowan E.G., Harvey A.L. Characterisation of muscarinic toxins MT1, MT2, MT3 and MT7. Toxicon. 36:1998;1251.
17. Brann M.R., Buckley N.J., Jones S.V.P., Bonner T.I. Expression of a cloned muscarinic receptor in A9L cells. Mol Pharmacol. 32:1987;450-455.
18. Brann M.R., Jørgansen H.B., Burstein E.S., Spalding T.A., Ellis J., Jones S.V.P., Hill-Eubanks D. Studies of the pharmacology, localization and structure of muscarinic acetylcholine receptors. Ann N Y Acad Sci. 707:1993;225-236.
19. Brown D.A., Higashida H., Noda M., Ishizaka N., Hashi M., Hoshi N., Yokoyama S., Fukuda K., Katayama M., Nukada T., Kameyama K., Robbins J., Marsh S.J., Selyanko A.A. Coupling of muscarinic receptor subtypes to ion channels. experiments on neuroblastoma hybrid cells Ann N Y Acad Sci. 707:1993;237-258.
20. th edn:1996;141-160 McGraw-Hill, London.
21. Buckley N.J., Bonner T.I., Brann M.R. Localization of a family of muscarinic receptor mRNAs in rat brain. J Neurosci. 8:1988;4646-4652.
22. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol. 35:1989;469-476.
23. Burford N.T., Tobin A.B., Nahorski S.R. Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol 1,4,5-triphosphate and adenosine 3′,5′-cyclic monophosphate accumulation in Chinese hamster ovary cells. J Pharmacol Exp Ther. 274:1995;134-142.
24. Caulfield M.P. Muscarinic receptors, characterisation, coupling and function. Pharmacol Ther. 58:1993;319-379.
25. Cerveñansky C., Dajas F., Harvey A.L., Karlsson E. Fasciculins, anticholinesterase toxins from mamba venoms. biochemistry and pharmacology Harvey A.L. Snake Toxins, Section 134 of the International Encyclopedia of Pharmacology and Therapeutics. 1991;303-321 Pergamon, Elmsford.
26. Clark A.L., Mitchelson F. The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol. 58:1976;323-331.
27. Cushman D.W., Ondetti M.A., Gordon E.M., Natarajan S., Karanewsky D.S., Krapcho J., Petrillo E.W. Jr. Rational design and biochemical utility of angiotensin-converting enzyme. J Cardiovasc Pharmacol. 10:1987;S17-S30.
28. De Weille J.R., Schweitz H., Maes P., Tartar A., Lazdunski M. Calciseptine, a peptide from black mamba venom, is a specific blocker of the L-type calcium channel. Proc Natl Acad Sci USA. 88:1991;2437-2440.
29. 3H]acetylcholine release from rat striatum by muscarinic receptor agonists. Br J Pharmacol. 124:1998;1213-1218.
30. Ducancel F., Rowan E.G., Cassar E., Harvey A.L., Ménez A., Boulain J.-C. Amino acid sequence of a muscarinic toxin deduced from the cDNA nucleotide sequence. Toxicon. 29:1991;516-520.
31. Eglen R.M., Hedge S.S. Muscarinic receptor subtypes. pharmacology and therapeutic potential Drug News Perspect. 10:1997;462-469.
32. Eglen R.M., Reddy H., Watson N., Challis J. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci. 15:1994;114-119.
33. Ehlert F.J. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. J Pharmacol Exp Ther. 247:1988;596-602.
34. Ehlert F.J., Ostrom R.S., Sawyer G.W. Subtypes of the muscarinic receptor in smooth muscle. Life Sci. 61:1997;1729-1740.
35. Ellis J., Huyler J., Brann M.R. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem Pharmacol. 42:1991;1927-1932.
36. Endo Y., Sato S., Ishii S., Tamiya N. The disulphide bonds of erabutoxin a, a neurotoxic protein of a sea-snake (Laticauda semifasciata) venom. Biochem J. 122:1971;463-467.
37. Felder C. Muscarinic acetylcholine receptors. signal transduction through multiple effectors FASEB J. 9:1995;619-625.
38. 1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update. Ann N Y Acad Sci. 777:1996;189-196.
39. 3 muscarinic cholinergic receptor of high molecular weight couples to phosphoinositide hydrolysis in human SK-N-SH neuroblastoma cells. J Neurochem. 50:1988;984-987.
40. Gross J., Waelbroeck M., Mutschler E., Lambrecht G. Functional characterisation of neuronal muscarinic receptors in rabbit anococcygeus muscle. Life Sci. 56:1995;1038.
41. 4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle. Naunyn Schmiedebergs Arch Pharmacol. 356:1997;505-516.
42. Hammer R., Berrie C.P., Birdsall N.J.M., Burgen A.S.V., Hulme E.C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 283:1980;90-92.
43. 1 receptor partial agonist, in the marmoset. Br J Pharmacol. 124:1998;409-415.
44. Harvey A.L. Presynaptic effect of toxins. Int Rev Neurobiol. 32:1990;201-239.
45. Harvey A.L., Anderson A. Dendrotoxins. snake toxins that block potassium channels and facilitate neurotransmitter release Harvey A.L. Snake Toxins, Section 134 of the International Encyclopedia of Pharmacology and Therapeutics. 1991;131-163 Pergamon Press, Elmsford.
46. 1 cholinoceptors. Can J Physiol Pharmacol. 72:1994;376.
47. Harvey A.L., Cerveñansky C., Kornisiuk E., Jerusalinsky D.A. Muscarinic toxin MTx1 from green mamba venom also interacts with α-adrenoceptors. Life Sci. 56:1995;1014.
48. Hejnová L., Tucek S., El-Fakahany E.E. Positive and negative allosteric interactions on muscarinic receptors. Eur J Pharmacol Mol Pharmacol Sect. 291:1995;427-430.
49. Henis Y.I., Kloog Y., Sokolovsky M. Allosteric interactions of muscarinic receptors and their regulation by other membrane proteins. Brown J.H. The Muscarinic Receptors. 1989;377-418 Humana Press, Clifton.
50. Hibert M.F., Trumpp-Kallmeyer S., Bruinvels A., Hoflack J. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol Pharmacol. 40:1991;8-15.
51. Hulme E., Birdsall N., Buckley N. Muscarinic receptor subtypes. Annu Rev Pharmac Toxicol. 30:1990;633-673.
52. 5 muscarinic acetylcholine receptors. J Pharmacol Exp Ther. 274:1995;1077-1083.
53. Jakubík J., Bacáková L., Lisá V., El-Fakahany E.E., Tucek S. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc Natl Acad Sci USA. 93:1996;8705-8709.
54. Jakubík J., Bacáková L., El-Fakahany E.E., Tucek S. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic receptors. Mol Pharmacol. 52:1997;172-179. a.
55. Jakubík J., Bacáková L., El-Fakahany E.E., Tucek S. The affinity of muscarinic receptors for their agonists can be increased by allosteric modulators. J Neurochem. 69:1997;S240. b.
56. Järv J. Neurotoxic agents interacting with the muscarinic acetylcholine receptor. Herken H., Hucho F. Selective Neurotoxicity, Vol. 102, Handbook of Experimental Pharmacology. 1992;659-680 Springer-Verlag, Berlin and Heidelberg.
57. Jauregui-Adell J., Marti J. Acidic cleavage of the aspartyl-proline bond and the limitations of the reaction. Anal Biochem. 69:1975;468-473.
58. Jerusalinsky D., Harvey A.L. Toxins from mamba venoms. small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors Trends Pharmacol Sci. 15:1994;424-430.
59. Jerusalinsky D., Cerveñansky C., Abó V., Kornisiuk E., Dajas F. Muscarinic cholinergic toxins from Dendroaspis angusticeps venom. J Neurochem. 57:1991;S93.
60. Jerusalinsky D., Cerveñansky C., Pena C., Raskovsky S., Dajas F. Two polypeptides from Dendroaspis angusticeps venom inhibit selectively the binding of central muscarinic cholinergic receptor ligands. Neurochem Int. 20:1992;237-246.
61. Jerusalinsky D., Cerveñansky C., Walz R., Biachin M., Izquierdo I. A peptide muscarinic toxin from the green mamba venom shows agonist-like action in an inhibitory avoidance learning task. Eur J Pharmacol. 240:1993;103-105.
62. 1 cholinoceptors. leads from muscarinic toxins from mamba snake venoms Neurobiol Aging. 15:1994;S102. a.
63. Jerusalinsky D., Raskovsky S., Kornisiuk E., Bernabeu R., Cerveñansky C. Muscarinic toxins from the venom of elapid snakes. Tipton K., Dajas F. Neurotoxins in Neurobiology. 1994;89-102 Ellis Horwood Ltd, Chichester. b.
64. 3 subtypes of muscarinic acetylcholine receptors. J Neurochem. 65:1995;S152. a.
65. Jerusalinsky D., Kornisiuk E., Bernabeu R., Izquierdo I., Cerveñansky C. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions. Toxicon. 33:1995;389-397. b.
66. 1 muscarinic cholinoceptors by MTx1, a protein from green mamba venom. Life Sci. 56:1995;1015. c.
67. Jerusalinsky D., Kornisiuk E., Harvey A.L. Muscarinic toxins and muscarinic acetylcholine receptors. Lazarovici P. Receptors and Signal Transduction. 1997;35-52 Ellis Horwood Ltd, Chicester.
68. Jerusalinsky D., Kornisiuk E., Alfaro A., Quillfeldt J., Alonso M., Verde E.R., Cerveñansky C., Harvey A.L. Muscarinic toxin selective for m4 receptors impairs memory in the rat. Neuroreport. 9:1998;1407-1411.
69. Jolkkonen, M. (1996). Muscarinic toxins from Dendroaspis (mamba) venoms. Peptides selective for subtypes of acetylcholine muscarinic receptors. Ph.D. Thesis. University of Uppsala.
70. Jolkkonen M., Toomela T., Rinken A., Satyapan N., Järv J., Adem A., Karlsson E. Muscarinic toxins from mamba venoms. Toxicon. 31:1993;524.
71. Jolkkonen M., van Giersbergen P., Hellman U., Werndstedt C., Karlsson E. A toxin from the green mamba Dendroaspis angusticeps. amino acid sequence and selectivity for muscarinic m4 receptors FEBS Lett. 352:1994;91-94.
72. Jolkkonen M., Adem A., Hellman U., Wernstedt C., Karlsson E. A snake toxin against muscarinic acetylcholine receptors. amino acid sequence, subtype specificity and effect on the guinea pig ileum Toxicon. 33:1995;399-410. a.
73. Jolkkonen M., Van Giersbergen P.L.M., Hellman U., Wernstedt C., Oras A., Satyapan N., Adem A., Karlsson E. Muscarinic toxins from the black mamba Dendroaspis polylepis. Eur J Biochem. 234:1995;579-585. b.
74. Jones S.V.P. Muscarinic receptor subtypes. modulation of ion channels Life Sci. 52:1993;457-464.
75. Karlsson E., Risinger C., Jolkkonen M., Wernstedt C., Adem A. Amino acid sequence of a snake venom toxin that binds to the muscarinic acetylcholine receptor. Toxicon. 29:1991;521-526.
76. Karlsson E., Jolkkonen M., Satyapan N., Adem A., Kumlin E., Hellman U., Wernstedt C. Protein toxins that bind to muscarinic acetylcholine receptors. Ann N Y Acad Sci. 710:1994;153-161.
77. Kenakin T., Boselli C. Pharmacological discrimination between receptor heterogeneity and allosteric interactions. resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea J Pharmacol Exp Ther. 250:1989;944-952.
78. 2 J Biol Chem. 271:1996;17476-17484.
79. Kornisiuk E., Cervenañsky C., Alfaro P., Bassarky M., Harvey A.L. Peptide muscarinic toxins with agonist activity that preferentially bind to the m1 receptor subtype. Commun Biol. 13:1995;123-133. a.
80. Kornisiuk E., Jerusalinsky D., Cerveñansky C., Harvey A.L. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba (Dendroaspis angusticeps) to cloned human muscarinic cholinoceptors. Toxicon. 33:1995;11-18. b.
81. Kornisiuk E., Jerusalinsky D., Cerveñansky C., Harvey A.L. Corrigendum. Toxicon. 33:1995;1111. c.
82. Kubo T., Fukuda K., Mikami A., Maeda A., Takahashi H., Mishina M., Haga T., Haga K., Ichiyama A., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 323:1986;411-416. a.
83. Kubo T., Maeda A., Sugimoto K., Akiba I., Takahashi H., Haga T., Haga K., Ichiyama A., Kangawa K., Matsuo H., Hirose T., Numa S. Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett. 209:1986;367-372. b.
84. Landon M. Cleavage at aspartyl-prolyl bonds. Methods Enzymol. 47:1977;145-149.
85. 4 binding sites in rabbit lung, chicken heart and NG108-15 cells. Mol Pharmacol. 38:1990;805-815.
86. Lee C.Y., Tsai M.C., Tsaur M.L., Lin W.W., Carlsson F.H.H., Joubert F.J. Pharmacological study on Angusticeps-type toxins from mamba snake venoms. J Pharmacol Exp Ther. 233:1985;491-498.
87. Lee Son S., Waud B.E. Potencies of neuromuscular blocking agents at the receptors of the atrial pacemaker and motor endplate of the guinea pig. Anesthesiology. 47:1977;34-36.
88. Lee Son S., Waud D.R. A vagolytic action of neuromuscular blocking agents at the pacemaker of the isolated guinea-pig atrium. Anesthesiology. 48:1978;191-194.
89. Levey A.I. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci. 52:1993;441-448.
90. Levey A.I., Kitt C.A., Simonds W.F., Price D., Brann M.R. Identification and localisation of muscarinic acetylcholine receptor proteins in brain with subtype-selective antibodies. J Neurosci. 11:1991;3218-3226.
91. Liang J.-S., Carsi-Cabrenas J., Krajewski J.L., McCafferty J.M., Purkerson S.L., Santiago M.P., Strauss W.L., Valentine H.H., Potter L.T. Anti-muscarinic toxins from Dendroaspis angusticeps. Toxicon. 34:1996;1257-1267.
92. Marshall R.J., Ojewole J.A.O. Comparison of the autonomic effects of some currently used neuromuscular blocking agents. Br J Pharmacol. 66:1979;77P-78P.
93. Max, S. I. (1992). M1-Toxin, a novel selective ligand for the M1 muscarinic acetylcholine receptor. Ph.D. Dissertation, University of Miami.
94. Max S.I., Liang J.-S., Potter L.T. Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol Pharmacol. 44:1993;1171-1175. a.
95. Max S.I., Liang J.-S., Potter L.T. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J Neurosci. 13:1993;4293-4300. b.
96. Max S.I., Liang J.-S., Purkerson S.L., Potter L.T. m4-toxin, a selective, reversible, allosteric antagonist of m4 muscarinic receptors. Soc Neurosci Abstr. 19:1993;462. c.
97. Max S.I., Liang J.-S., Valentine H.H., Potter L.T. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J Pharmacol Exp Ther. 267:1993;480-485. d.
98. Ménez A., Boulain J.-C., Bouet F., Couderc J., Fayre G., Rousselet A., Trémeau O., Gatineau E., Fromageot P. On the molecular mechanisms of neutralisation of cobra neurotoxins by specific antibodies. J Physiol Paris. 79:1984;196-206.
99. Ménez R., Ledu M.H., Ménez A. Three-dimensional structure of muscarinic toxin 2 from Dendroaspis angusticeps venom. Toxicon. 36:1998;1557-1572.
100. Mitchelson F. Muscarinic receptor differentiation. Pharmacol Ther. 37:1988;357-423.
101. 2 from Naja naja sputatrix venom is a muscarinic acetylcholine receptor inhibitor. Arch Biochem Biophys. 328:1996;17-25.
102. 1 dependent turning behaviour in 6-hydroxydopamine-lesioned rats. Neuroscience. 53:1993;673-678.
103. Nordvall G., Hacksell U. Binding-site modelling of the m1-receptor. a combination of homology-based and indirect approaches J Med Chem. 36:1993;967-976.
104. Olianas M.C., Adem A., Karlsson E., Onali P. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity. potent block by the selective m4 ligand muscarinic toxin 3 (MT3) Br J Pharmacol. 118:1996;283-288.
105. 4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3. Eur J Pharmacol. 357:1998;235-242.
106. Onali P., Olianas M.C. Identification and characterisation of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotrophin-releasing hormone in membranes rat frontal cortex. J Pharmacol Exp Ther. 286:1998;753-759.
107. Othman O., Ismail M., El-Asmar M. Pharmacological studies of snake (Dendroaspis angusticeps) venom. Toxicon. 11:1973;185-192.
108. Parker E.M., Kameyama K., Higashima T., Ross E.M. Reconstitutively active G-protein-coupled receptors purified from baculovirus-infected insect cells. J Biol Chem. 266:1991;519-527.
109. Peralta E.G., Ashkenazi A., Winslow J.W., Ramachandran J., Capon D.J. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature. 334:1987;434-437. a.
110. Peralta E.G., Ashkenazi A., Winslow J.W., Smith D.H., Ramachandran J., Capon D.J. Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6:1987;3923-3929. b.
111. Piszkiewicz D., Landon M., Smith E.L. Anomalous cleavage of aspartyl-proline peptide bonds during amino acid sequence determination. Biochem Biophys Res Commun. 40:1970;1173-1178.
112. Potter L.T., Purkerson S.L. Pharmacology of striatal muscarinic receptors. Ariano M.A., Surmeier D.J. Molecular and Cellular Mechanisms of Neostriatal Function. 1995;241-254 R.G. Landes Co, Georgetown.
113. Potter L.T., Hanchett-Valentine H., Liang J.-S., Max S.I., Purkerson S.L., Silberberg H.A., Strauss W.L. m1-toxin. Life Sci. 52:1993;433-440.
114. Proška J., Tucek S. Competition between positive and negative allosteric effectors on muscarinic receptors. Mol Pharmacol. 48:1995;696-702.
115. Purkerson S.L., Potter L.T. Use of anti-muscarinic toxins to facilitate studies of striatal m4 muscarinic receptors. J Pharmacol Exp Ther. 284:1998;707-713.
116. Raiteri M., Marchi M., Paudice P. Presynaptic muscarinic receptors in the central nervous system. Ann N Y Acad Sci. 604:1990;113-129.
117. Rang H.P., Dale M.M. Pharmacology. 1991;Churchill Livingstone, Edinburgh, London, Melbourne, New York, Tokyo and Madrid.
118. Rathburn F.J., Hamilton J.T. Effect of gallamine on cholinergic receptors. Can Anaesth Soc J. 17:1970;574-589.
119. Read R.J., Stein P.E. Toxins. Curr Opin Struct Biol. 3:1993;853-860.
120. Rees B., Bilwes A. Three-dimensional structures of neurotoxins and cardiotoxins. Chem Res Toxicol. 6:1993;385-406.
121. Riker W.F., Wescoe W.C. The pharmacology of flaxedil with observations on certain analogues. Ann N Y Acad Sci. 54:1951;373-392.
122. Ségalas I., Roumestand C., Zinn-Justin S., Gilquin B., Ménez R., Ménez A., Toma F. Solution structure of a green mamba toxin that activates muscarinic acetylcholine receptors, as studied by nuclear magnetic resonance and molecular modelling. Biochemistry. 34:1995;1248-1260. a.
123. Ségalas I., Thai R., Ménez R., Vita C. A particularly labile Asp-Pro bond in the green mamba muscarinic toxin MTx2. Effect of protein conformation on the rate of cleavage. FEBS Lett. 371:1995;171-175. b.
124. 3H]pirenzepine binding associated with hydrolysis of phosphoinositols. J Neurochem. 50:1988;1513-1521.
125. + channel critical for activation by G protein βγ subunits. Neuron. 13:1994;747-755.
126. Takechi M., Hayashi K. Localisation of the four disulphide bridges in cytotoxin II from the venom of the Indian cobra (Naja naja). Biochem Biophys Res Commun. 49:1973;584-590.
127. Toomela T., Jolkkonen M., Rinken A., Järv J., Karlsson E. Two-step binding of green mamba toxin to muscarinic acetylcholine receptor. FEBS Lett. 352:1994;95-97.
128. Tränkle C., Kostenis E., Burgmer U., Mohr K. Search for lead structures to develop new allosteric modulators of muscarinic receptors. J Pharmacol Exp Ther. 279:1996;926-933.
129. Trumpp-Kallmeyer S., Hoflack J., Bruinvels A., Hibert M.F. Modelling of G-protein coupled receptors. application to dopamine, adrenaline, serotonin, acetylcholine and mammalian opsin receptors J Med Chem. 35:1992;3448-3462.
130. Tsernoglou D., Petsko G.A. The crystal structure of a postsynaptic-neurotoxin from sea-snake at 2.2 Å resolution. FEBS Lett. 68:1976;1-4.
131. Tu A.T. Neurotoxins in snake venom. Chimia. 52:1998;56-62.
132. Tucek S., Proška J. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci. 16:1995;205-212.
133. Valentine H.-H., Carsi-Gabrenas J., Potter L.T. m2-toxin, a selective ligand for m2 muscarinic receptors. Soc Neurosci Abstr. 22:1996;1257.
134. Vandermeers A., Vandermeers-Piret M.-C., Rathé J., Waelbroeck M., Jolkkonen M., Oras A., Karlsson E. Purification and sequence determination of a new muscarinic toxin (MT4). from the venom of the green mamba (Dendroaspis angusticeps). Toxicon. 33:1995;1171-1179.
135. Vincent A., Lang B., Clover L., Garcia M. Use of snake, spider, snail and scorpion neurotoxins to investigate autoimmune neurological disorders. Toxicon. 37:1999;279.
136. 4) in rat forebrain. Mol Pharmacol. 38:1990;267-273.
137. 125I-MT1 to rat brain muscarinic receptors. Life Sci. 56:1995;1014.
138. 1 receptors. Eur J Pharmacol. 305:1996;187-192.
139. Wang J., Jolkkonen M., McGinty J.F. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum in vivo. Eur J Pharmacol. 334:1997;43-47.
140. Waud D.R., Lee Son S., Waud B.E. Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example. Life Sci. 22:1978;1275-1286.
141. Welsh J. Acetylcholine in snake venoms. Russell F.E., Saunders P.R. Animal Toxins. 1967;363-368 Pergamon Press, New York.
142. Wess J. Mutational analysis of muscarinic acetylcholine receptors. structural basis of ligand/receptor/G-protein interactions Life Sci. 53:1993;1447-1463. a.
143. Wess J. Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol Sci. 14:1993;308-313. b.
144. Wess J., Buhl T., Lambrecht G., Mutchler E. Cholinergic receptors. Emmett J.C. Comprehensive Medicinal Chemistry, Vol. 3. 1990;423-491 Pergamon Press, Oxford.
145. Yang C.C., Yang H.J., Chiu R.H.C. The position of disulphide bonds in cobrotoxin. Biochim Biophys Acta. 214:1970;355-363.